0000899243-22-034263.txt : 20221026
0000899243-22-034263.hdr.sgml : 20221026
20221026161541
ACCESSION NUMBER: 0000899243-22-034263
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221020
FILED AS OF DATE: 20221026
DATE AS OF CHANGE: 20221026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hagen Brett R
CENTRAL INDEX KEY: 0001681782
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 221333421
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE, 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-10-20
2022-10-24
0
0001754068
Allovir, Inc.
ALVR
0001681782
Hagen Brett R
C/O ALLOVIR, INC.
1100 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Accounting Officer
Common Stock
2022-10-20
4
S
0
345
9.3607
D
113233
D
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This Form 4/A is being filed correct the transaction date reported in the original Form 4 filed on October 24, 2022.
/s/ Brett Hagen
2022-10-26